Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)
A Double Blind Randomised Control Trial Investigating the Efficacy of Platelet Rich Plasma Versus Placebo for the Treatment of Greater Trochanteric Pain Syndrome (HiPPO Trial)
Sponsor: Northumbria Healthcare NHS Foundation Trust
This NA trial investigates Greater Trochanteric Pain Syndrome and is currently completed. Northumbria Healthcare NHS Foundation Trust leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Oct 2021 — Apr 2023 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Sep 2019 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Northumbria Healthcare NHS Foundation Trust
For direct contact, visit the study record on ClinicalTrials.gov .